BioSpace News Archive

Deals

Spherix to Merge with CBM BioPharma Pharmaceutical Company

Spherix Incorporated (Nasdaq: SPEX) today announced that it has entered into a merger agreement with CBM BioPharma, Inc.

October 11, 2018
·
6 min read
FDA

FDA Approves Stiolto® Respimat® Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) approved new labeling for Stiolto Respimat

October 11, 2018
·
11 min read
Business

Steven Zatz Joins WebMD Board of Directors

WebMD Health Corp., an Internet Brands company, today announced that Steven Zatz, M.D., is joining WebMD’s Board of Directors, effective immediately.

October 11, 2018
·
3 min read
Drug Development

Bausch Health Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On ALTRENO™ (tretinoin) Lotion, 0.05% In The Journal Of Drugs In Dermatology

ALTRENO Lotion Provides Statistically Significant Greater Efficacy Over Vehicle with a Favorable Safety and Tolerability Profile in Two Pivotal Clinical Trials1

October 11, 2018
·
9 min read
Pharm Country

Greenphire to Moderate Panel at the 2018 Global Site Solutions Summit

Global leader of clinical trial payment automation solutions to host discussion on patient retention and its role in study success.

October 11, 2018
·
2 min read
Business

Sebacia EU Real-World Results Demonstrate an Average 79% Improvement in Acne at 6 Months

Oral presentation today at ASDS Annual Meeting by leading dermatologist Ashish Bhatia, MD

October 11, 2018
·
3 min read
Pharm Country

Helping Older Kidney Patients Make Fundamental Care Decisions

The National Kidney Foundation is collaborating with Tufts University on a three-year project to help older patients with advanced stages of kidney disease and their family care partners make decisions that best reflect their goals and preferences for care.

October 11, 2018
·
5 min read
Business

Incyte to Report 2018 Third Quarter Financial Results

Incyte Corporation announced today that it has scheduled its third quarter 2018 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 30, 2018.

October 11, 2018
·
1 min read
Business

AtriCure to Announce Third Quarter 2018 Financial Results

AtriCure will release its third quarter 2018 financial results on Thursday, November 1, 2018.

October 11, 2018
·
1 min read
Policy

Evecxia Licenses Additional IP from NUS, NUH and NTU in Singapore

Evecxia has licensed exclusive, world-wide rights to develop and commercialize novel formulations for improving the bioavailability and pharmacokinetics of 5-hydroxytryptophan

October 11, 2018
·
2 min read